The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
Crossref DOI link: https://doi.org/10.1038/s41419-020-2445-9
Published Online: 2020-04-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Liren
Zawacka-Pankau, Joanna
Text and Data Mining valid from 2020-04-17
Version of Record valid from 2020-04-17
Article History
Received: 28 January 2020
Revised: 9 March 2020
Accepted: 1 April 2020
First Online: 17 April 2020
Conflict of interest
: The authors declare that they have no conflict of interest.